Tilray Brands Files Definitive Proxy Statement
Ticker: TLRY · Form: DEF 14A · Filed: 2024-09-27T00:00:00.000Z
Sentiment: neutral
Topics: proxy-statement, governance, annual-meeting
Related Tickers: TLRY
TL;DR
Tilray Brands (TLRY) filed its proxy statement for the Nov 21 meeting. Get ready to vote.
AI Summary
Tilray Brands, Inc. filed its definitive proxy statement (DEF 14A) on September 27, 2024, for its annual meeting on November 21, 2024. The filing provides details for shareholders regarding the company's governance and upcoming votes. Tilray Brands, Inc. is a company operating in the medicinal chemicals and botanical products sector.
Why It Matters
This filing is crucial for shareholders as it outlines the proposals and director nominations they will vote on at the upcoming annual meeting, impacting the company's future direction and leadership.
Risk Assessment
Risk Level: low — This is a routine regulatory filing (DEF 14A) providing information to shareholders, not announcing new material events or financial results.
Key Numbers
- 23 — Public Documents (Number of documents included in the filing.)
Key Players & Entities
- Tilray Brands, Inc. (company) — Registrant
- 20240927 (date) — Filing Date
- 20241121 (date) — Meeting Date
- 0001140361-24-042191 (filing_id) — Accession Number
FAQ
What is the purpose of a DEF 14A filing?
A DEF 14A filing, also known as a Definitive Proxy Statement, is used by companies to solicit proxy votes from shareholders for their annual or special meetings, providing detailed information on matters to be voted upon.
When is the scheduled meeting date for Tilray Brands, Inc.?
The filing indicates that the Conformed Period of Report is 20241121, which is the date of the shareholder meeting.
What is Tilray Brands, Inc.'s Standard Industrial Classification (SIC) code?
Tilray Brands, Inc.'s SIC code is 2833, which corresponds to MEDICINAL CHEMICALS & BOTANICAL PRODUCTS.
What is the filing date of this DEF 14A?
This DEF 14A filing was made on September 27, 2024.
Has Tilray Brands, Inc. operated under a different name previously?
Yes, the company was formerly known as Tilray, Inc., with a date of name change on 20180213.
From the Filing
0001140361-24-042191.txt : 20240927 0001140361-24-042191.hdr.sgml : 20240927 20240927161734 ACCESSION NUMBER: 0001140361-24-042191 CONFORMED SUBMISSION TYPE: DEF 14A PUBLIC DOCUMENT COUNT: 23 CONFORMED PERIOD OF REPORT: 20241121 FILED AS OF DATE: 20240927 DATE AS OF CHANGE: 20240927 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Tilray Brands, Inc. CENTRAL INDEX KEY: 0001731348 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 824310622 FISCAL YEAR END: 0531 FILING VALUES: FORM TYPE: DEF 14A SEC ACT: 1934 Act SEC FILE NUMBER: 001-38594 FILM NUMBER: 241335105 BUSINESS ADDRESS: STREET 1: 655 MADISON AVENUE STREET 2: 19TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10065 BUSINESS PHONE: 519.322.8800 MAIL ADDRESS: STREET 1: 655 MADISON AVENUE STREET 2: 19TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10065 FORMER COMPANY: FORMER CONFORMED NAME: Tilray, Inc. DATE OF NAME CHANGE: 20180213 DEF 14A 1 ny20034373x2_def14a.htm DEF 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant    ☐ Check the appropriate box:   ☐ Preliminary Proxy Statement   ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Definitive Proxy Statement   ☐ Definitive Additional Materials    ☐ Soliciting Material Pursuant to § 240.14a-12         Tilray Brands, Inc.     (Name of Registrant as Specified in its Charter)           (Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)         Payment of Filing Fee (Check the appropriate box):               ☒     No fee required.       ☐     Fee paid previously with preliminary materials.       ☐     Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.                 2024 PROXY STATEMENT     September 26, 2024 Dear Fellow Stockholders: You are cordially invited to attend the Annual Meeting of Stockholders (“ Annual Meeting ”) of Tilray Brands, Inc. (the “ Company ”) to be held on Thursday, November 21, 2024, at 11:00 a.m. EST. The Annual Meeting will be held in a virtual format, via live webcast over the internet. Attached to this letter are a Notice of Annual Meeting of Stockholders and Proxy Statement, which describe the business to be conducted at the Annual Meeting. Our Board of Directors (the “ Board ”) urges you to read the accompanying Proxy Statement and recommends that you vote “ FOR ”: • The election of each of David Hopkinson and Thomas Looney, as Class III director nominees, each to serve until his term expires or until his successor is duly elected and qualified, as described herein; • The ratification of the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending May 31, 2025; • Approval to increase the number of shares of common stock the Company is authorized to issue from 1,208,000,000 shares of capital stock to 1,426,000,000 shares of capital stock (the “ Authorized Shares Proposal ”); • Approval of the governance changes to the Company’s Fourth Amended and Restated Certificate of Incorporation (the “ Charter ”) to (i) declassify the Board and provide that all directors will be elected at each annual meeting o